The Court of Appeal sitting in Yola has formally upheld the conviction of a member of the National Association of Patent and Proprietary Medicines Dealers (NAPPMED), John Japtu, for the illegal operation of a medicine outlet. This landmark judicial decision marks a significant victory for the Pharmacy Council of Nigeria (PCN) in its ongoing efforts to sanitize the pharmaceutical landscape and ensure that the distribution of medicines adheres to stringent national safety standards. The appellate court’s ruling, delivered on Wednesday, September 16, 2026, reinforces the statutory authority of the PCN to regulate, inspect, and license all pharmaceutical premises across the country, effectively shutting down legal challenges that seek to undermine professional oversight.

Chronology of Legal Proceedings

The legal saga began in 2017 when the Pharmacy Council of Nigeria identified Japtu’s medicine outlet as operating without the requisite registration and licensing mandated by the Pharmacy Council of Nigeria Act. Following an enforcement exercise, the PCN initiated criminal proceedings against the appellant at the Federal High Court in Yola, registered as Charge No. FHC/YL/94C/2017. The court found Japtu guilty of violating established protocols regarding the sale and distribution of pharmaceuticals, noting that his operations posed an unregistered risk to the local community.

Dissatisfied with the Federal High Court’s verdict, Japtu sought redress at the Court of Appeal (Appeal No. CA/YL/269/2025). The appellant’s defense centered on the argument that his business activities constituted a lawful trade and that the PCN had allegedly exceeded its statutory powers by sealing his premises and facilitating his arrest. However, the appellate justices scrutinized the legal framework governing pharmaceutical practice in Nigeria. Upon thorough review, the court concluded that the appellant’s arguments lacked legal merit, affirming that the PCN acted strictly within the ambit of its mandate to protect the public from substandard, falsified, or improperly handled medication.

The Role of the Pharmacy Council of Nigeria

The Pharmacy Council of Nigeria serves as the primary regulatory body responsible for the control and management of pharmacy practice in all its aspects and ramifications. Its core mandate includes the training, registration, and licensing of pharmacists and pharmaceutical premises. The PCN’s regulatory power is derived from federal statutes designed to ensure that the drug supply chain remains untainted.

In recent years, the Council has intensified its enforcement activities, conducting nationwide raids on illegal medicine shops. These outlets often lack the necessary temperature-controlled storage, qualified personnel, and supply chain documentation required to ensure that medicines remain safe and efficacious until they reach the consumer. The case against Japtu is emblematic of the Council’s broader strategy to move beyond administrative warnings and utilize the judicial system to create legal precedents that discourage unlicensed practice.

Implications for Public Health and Safety

The unauthorized sale of medicines is a critical public health concern in Nigeria. Unregulated outlets often procure drugs from unverified sources, increasing the risk of patients purchasing counterfeit or expired products. The World Health Organization (WHO) has frequently identified the proliferation of unregulated medicine vendors as a major contributor to the rise of antimicrobial resistance (AMR) and treatment failures.

By upholding this conviction, the Court of Appeal has signaled that the right to trade does not supersede the state’s obligation to protect citizens from health hazards. Experts in pharmaceutical law argue that this judgment provides the PCN with a stronger legal foundation to prosecute other offenders. If unregulated vendors can no longer claim that their businesses are "lawful" simply by virtue of being small-scale, the Council can expedite the closure of thousands of shops that currently operate outside the scope of the National Drug Distribution Guidelines (NDDG).

Stakeholder Perspectives and Official Response

Pharm. Ahmed Babashehu, the Registrar of the PCN, emphasized the significance of the ruling in a statement released following the judgment. He noted that the decision is a validation of the Council’s rigorous enforcement strategies. According to Babashehu, the judgment serves as a deterrent to those who prioritize financial gain over the safety of the Nigerian populace.

"The long arm of the law will catch up with those who put the health of the public in peril for financial gains," Babashehu stated. He further noted that the Council remains committed to creating a well-regulated environment that aligns with global best practices. By standardizing the distribution of medicines, the PCN aims to restore public confidence in the pharmacy sector, ensuring that every point of sale is a point of professional care.

While members of trade associations like NAPPMED have historically advocated for easier registration processes, the judiciary has remained firm in its stance that ease of business cannot come at the expense of safety protocols. The PCN has indicated that it is willing to work with legitimate, law-abiding vendors to ensure they meet the minimum requirements for licensure, provided they are willing to submit to regulatory supervision.

Data and Trends in Pharmaceutical Regulation

Statistical data from the PCN’s enforcement reports between 2020 and 2025 indicates that thousands of illegal medicine shops have been sealed across the country’s six geopolitical zones. The majority of these closures are attributed to the lack of a registered pharmacist on-site, improper storage conditions, and the sale of controlled substances without a valid prescription.

The persistence of the illegal market is largely attributed to the gap between the high demand for accessible healthcare in rural areas and the relatively lower number of registered community pharmacies. However, regulators argue that this gap does not justify the existence of dangerous, unregulated outlets. Instead, the government has been urged to incentivize the establishment of "Patent Medicine Stores" that are properly registered and supervised by the Council, rather than allowing the current system of unchecked proliferation to persist.

Future Outlook and Regulatory Compliance

The Court of Appeal’s decision is expected to have a ripple effect on future litigation involving the PCN. Lawyers specializing in administrative law note that the court’s dismissal of the appeal for "lack of merit" suggests that the judiciary is unlikely to entertain future claims of "overreach" when the PCN is clearly acting to enforce public health statutes.

For operators in the sector, the ruling serves as a final warning: compliance is not optional. The PCN has announced plans to integrate digital tracking for pharmaceutical outlets, which will allow for real-time monitoring of premises registration status. This technological push, combined with the judicial backing provided by the Yola court, marks a new chapter in the regulation of the Nigerian pharmaceutical sector.

As the industry moves toward greater professionalization, the burden now shifts to individual operators to ensure they are fully compliant. The PCN has reiterated that its enforcement exercises will continue unabated, with a focus on both metropolitan centers and remote regions where illegal operators have historically found safe harbor.

Conclusion

The conviction of John Japtu, now cemented by the Court of Appeal, is a pivotal moment in the history of pharmaceutical regulation in Nigeria. It underscores the critical intersection between judicial enforcement and public health. By affirming the authority of the Pharmacy Council of Nigeria, the court has provided a clear roadmap for the future: the pharmaceutical sector must be a controlled, regulated, and professional environment. As the PCN continues its mandate, the impact of this ruling will likely be felt in a reduction of illicit medicine distribution and a strengthened commitment to the rigorous standards that safeguard the health of every Nigerian citizen. This case acts as a reminder that the health of the nation is a non-negotiable priority, and the law stands firmly in defense of those who protect it.